Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


BIO-RAD LABS -A   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2020201920182017201620152014201320122011
Period End Date12/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/2011
Sales2,545.632,311.662,289.422,160.152,068.172,019.442,175.042,132.692,069.242,073.53
Total Revenues2,545.632,311.662,289.422,160.152,068.172,019.442,175.042,132.692,069.242,073.53
Cost of good sold1,107.801,054.661,066.26972.45929.74897.77996.53954.22914.08894.70
Gross Profit1,437.821,257.001,223.151,187.701,138.431,121.671,178.521,178.481,155.161,178.83
Goodwill amortization--------------------
Product research and development expense226.60202.71199.20250.16205.71192.97220.33210.95209.20177.60
Purchased in-process research and development expense--------------------
Selling, general and administrative expense800.27824.63834.78806.79814.70761.99808.20798.07681.78695.98
Impairment losses on goodwill and long-lived assets----(292.51)(11.51)(62.31)----------
Operating Income (loss)410.96229.66(103.34)119.2555.72166.71149.98169.46264.18305.24
Interest expense21.8623.4223.9623.0123.3821.6922.1361.2751.1153.14
Impairment losses on long-lived assets--------------------
Loss on divestitures--------------------
Change in fair market value of equity securities4,495.832,030.99606.23--------------
Other (income) expense, net24.4926.0936.5910.7013.7611.0813.0112.7721.887.58
Foreign exchange (gains) losses(1.77)(2.25)(2.86)(9.13)(4.54)(10.25)(9.31)(8.57)(5.04)(13.84)
Income before taxes4,907.642,261.08512.6697.8141.56145.85131.56112.39229.91245.85
Pre-Tax Income - International--------------------
Pre-Tax Income - U.S--------------------
Income from continuing operations before taxes1,101.37502.41147.05--------------
Provision for income taxes1,101.37502.41147.05(24.44)15.5636.6142.7134.5764.3667.03
Deferred tax expense--------------------
Deferred Tax--------------------
Current Tax : U.S--------------------
Current Tax : International--------------------
Deferred Tax : U.S--------------------
Deferred Tax : International--------------------
Current Tax : U.S. Federal--------------------
Current Tax : U.S. State--------------------
Deferred Tax : U.S. Federal--------------------
Deferred Tax : U.S. State--------------------
Non-current tax expense--------------------
Income from Continuing Operations--------------------
Discontinued operations : Gain on divestiture, net of tax benefits--------------------
Discontinued operations : Loss from discontinued operations--------------------
Total income from discontinued operations--------------------
Income before cumulative effect of change in accounting principle--------------------
Cumulative effect of accounting change, net of taxes--------------------
Net income including noncontrolling interests3,806.271,758.68365.61122.2526.00109.24--77.81165.55178.81
Less: Net income attributable to noncontrolling interests--------------0.020.07(0.20)
Net Income (Loss) Available to Common Shareholders3,806.271,758.68365.61122.2526.00109.2488.8577.79165.48179.01
Earnings Per Share (Basic) - Cont Ops--------------------
EPS (Basic) : Disc Ops--------------------
Cumulative effect of accounting change--------------------
Net income per share (basic)127.8658.9312.254.120.883.743.082.725.856.39
Earnings Per Share (Diluted) - Cont Ops--------------------
Earnings Per Share (Diluted) - Disc Ops--------------------
Cumulative effect of accounting change--------------------
Net income per share (diluted)126.2058.2712.104.070.883.713.052.695.786.29
Weighted Average Shares Outstsanding (Basic)29.7729.8429.8429.6629.4429.1928.8828.5928.2928.03
Weighted Average Shares Outstsanding (Diluted)30.1630.1830.2330.0329.6529.4129.1328.9128.6428.47